Cargando…

A multifactorial analysis of FAP to regulate gastrointestinal cancers progression

BACKGROUND: Fibroblast activation protein (FAP) is a cell-surface serine protease that has both dipeptidyl peptidase as well as endopeptidase activities and could cleave substrates at post-proline bond. Previous findings showed that FAP was hard to be detected in normal tissues but significantly up-...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jialing, Yang, Depeng, Sun, Handi, Xiao, Lixing, Han, Fang, Zhang, Mengmeng, Zhou, Lu, Jiang, Meiyi, Jiang, Qinghua, Li, Yu, Nie, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262038/
https://www.ncbi.nlm.nih.gov/pubmed/37325617
http://dx.doi.org/10.3389/fimmu.2023.1183440
_version_ 1785057992838742016
author Cai, Jialing
Yang, Depeng
Sun, Handi
Xiao, Lixing
Han, Fang
Zhang, Mengmeng
Zhou, Lu
Jiang, Meiyi
Jiang, Qinghua
Li, Yu
Nie, Huan
author_facet Cai, Jialing
Yang, Depeng
Sun, Handi
Xiao, Lixing
Han, Fang
Zhang, Mengmeng
Zhou, Lu
Jiang, Meiyi
Jiang, Qinghua
Li, Yu
Nie, Huan
author_sort Cai, Jialing
collection PubMed
description BACKGROUND: Fibroblast activation protein (FAP) is a cell-surface serine protease that has both dipeptidyl peptidase as well as endopeptidase activities and could cleave substrates at post-proline bond. Previous findings showed that FAP was hard to be detected in normal tissues but significantly up-regulated in remodeling sites like fibrosis, atherosclerosis, arthritis and embryonic tissues. Though increasing evidence has demonstrated the importance of FAP in cancer progression, no multifactorial analysis has been developed to investigate its function in gastrointestinal cancers until now. METHODS: By comprehensive use of datasets from The Cancer Genome Atlas (TCGA), Clinical Proteomic Tumor Analysis Consortium (CPTAC), scTIME Portal and Human Protein Atlas (HPA), we evaluated the carcinogenesis potential of FAP in gastrointestinal cancers, analyzing the correlation between FAP and poor outcomes, immunology in liver, colon, pancreas as well as stomach cancers. Then liver cancer was selected as example to experimentally validate the pro-tumor and immune regulative role of FAP in gastrointestinal cancers. RESULTS: FAP was abundantly expressed in gastrointestinal cancers, such as LIHC, COAD, PAAD and STAD. Functional analysis indicated that the highly-expressed FAP in these cancers could affect extracellular matrix organization process and interacted with genes like COL1A1, COL1A2, COL3A1 and POSTN. In addition, it was also observed that FAP was positively correlated to M2 macrophages infiltration across these cancers. To verify these findings in vitro, we used LIHC as example and over-expressed FAP in human hepatic stellate LX2 cells, a main cell type that produce FAP in tumor tissues, and then investigate its role on LIHC cells as well as macrophages. Results showed that the medium from FAP-over-expressed LX2 cells could significantly promote the motility of MHCC97H and SK-Hep1 LIHC cells, increase the invasion of THP-1 macrophages and induce them into pro-tumor M2 phenotype. CONCLUSION: In summary, we employed bioinformatic tools and experiments to perform a comprehensive analysis about FAP. Up-regulation of FAP in gastrointestinal cancers was primarily expressed in fibroblasts and contributes to tumor cells motility, macrophages infiltration and M2 polarization, revealing the multifactorial role of FAP in gastrointestinal cancers progression.
format Online
Article
Text
id pubmed-10262038
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102620382023-06-15 A multifactorial analysis of FAP to regulate gastrointestinal cancers progression Cai, Jialing Yang, Depeng Sun, Handi Xiao, Lixing Han, Fang Zhang, Mengmeng Zhou, Lu Jiang, Meiyi Jiang, Qinghua Li, Yu Nie, Huan Front Immunol Immunology BACKGROUND: Fibroblast activation protein (FAP) is a cell-surface serine protease that has both dipeptidyl peptidase as well as endopeptidase activities and could cleave substrates at post-proline bond. Previous findings showed that FAP was hard to be detected in normal tissues but significantly up-regulated in remodeling sites like fibrosis, atherosclerosis, arthritis and embryonic tissues. Though increasing evidence has demonstrated the importance of FAP in cancer progression, no multifactorial analysis has been developed to investigate its function in gastrointestinal cancers until now. METHODS: By comprehensive use of datasets from The Cancer Genome Atlas (TCGA), Clinical Proteomic Tumor Analysis Consortium (CPTAC), scTIME Portal and Human Protein Atlas (HPA), we evaluated the carcinogenesis potential of FAP in gastrointestinal cancers, analyzing the correlation between FAP and poor outcomes, immunology in liver, colon, pancreas as well as stomach cancers. Then liver cancer was selected as example to experimentally validate the pro-tumor and immune regulative role of FAP in gastrointestinal cancers. RESULTS: FAP was abundantly expressed in gastrointestinal cancers, such as LIHC, COAD, PAAD and STAD. Functional analysis indicated that the highly-expressed FAP in these cancers could affect extracellular matrix organization process and interacted with genes like COL1A1, COL1A2, COL3A1 and POSTN. In addition, it was also observed that FAP was positively correlated to M2 macrophages infiltration across these cancers. To verify these findings in vitro, we used LIHC as example and over-expressed FAP in human hepatic stellate LX2 cells, a main cell type that produce FAP in tumor tissues, and then investigate its role on LIHC cells as well as macrophages. Results showed that the medium from FAP-over-expressed LX2 cells could significantly promote the motility of MHCC97H and SK-Hep1 LIHC cells, increase the invasion of THP-1 macrophages and induce them into pro-tumor M2 phenotype. CONCLUSION: In summary, we employed bioinformatic tools and experiments to perform a comprehensive analysis about FAP. Up-regulation of FAP in gastrointestinal cancers was primarily expressed in fibroblasts and contributes to tumor cells motility, macrophages infiltration and M2 polarization, revealing the multifactorial role of FAP in gastrointestinal cancers progression. Frontiers Media S.A. 2023-05-30 /pmc/articles/PMC10262038/ /pubmed/37325617 http://dx.doi.org/10.3389/fimmu.2023.1183440 Text en Copyright © 2023 Cai, Yang, Sun, Xiao, Han, Zhang, Zhou, Jiang, Jiang, Li and Nie https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Cai, Jialing
Yang, Depeng
Sun, Handi
Xiao, Lixing
Han, Fang
Zhang, Mengmeng
Zhou, Lu
Jiang, Meiyi
Jiang, Qinghua
Li, Yu
Nie, Huan
A multifactorial analysis of FAP to regulate gastrointestinal cancers progression
title A multifactorial analysis of FAP to regulate gastrointestinal cancers progression
title_full A multifactorial analysis of FAP to regulate gastrointestinal cancers progression
title_fullStr A multifactorial analysis of FAP to regulate gastrointestinal cancers progression
title_full_unstemmed A multifactorial analysis of FAP to regulate gastrointestinal cancers progression
title_short A multifactorial analysis of FAP to regulate gastrointestinal cancers progression
title_sort multifactorial analysis of fap to regulate gastrointestinal cancers progression
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262038/
https://www.ncbi.nlm.nih.gov/pubmed/37325617
http://dx.doi.org/10.3389/fimmu.2023.1183440
work_keys_str_mv AT caijialing amultifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT yangdepeng amultifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT sunhandi amultifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT xiaolixing amultifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT hanfang amultifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT zhangmengmeng amultifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT zhoulu amultifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT jiangmeiyi amultifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT jiangqinghua amultifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT liyu amultifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT niehuan amultifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT caijialing multifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT yangdepeng multifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT sunhandi multifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT xiaolixing multifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT hanfang multifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT zhangmengmeng multifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT zhoulu multifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT jiangmeiyi multifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT jiangqinghua multifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT liyu multifactorialanalysisoffaptoregulategastrointestinalcancersprogression
AT niehuan multifactorialanalysisoffaptoregulategastrointestinalcancersprogression